Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Non-Invasive Determination of Cardiac Output by Electrical Velocimetry

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Joachim Saur, University Hospital Mannheim
ClinicalTrials.gov Identifier:
NCT00945048
First received: July 21, 2009
Last updated: January 15, 2013
Last verified: January 2013
  Purpose

The cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of the CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore the aim of the study at hand was to evaluate the electrical velocimetry technique as a new method for determining the CO and to compare this new technique with the Inert Gas Rebreathing Method and with the Magnetic Resonance Tomography


Condition Intervention
Cardiac Diseases
Device: electrical velocimetry
Device: inert gas rebreathing
Device: spirometry
Device: cardiac magnetic resonance imaging (CMR)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Non-Invasive Determination of Cardiac Output by Electrical Velocimetry Compared With Magnetic Resonance Tomography and Inert Gas Rebreathing Method

Resource links provided by NLM:


Further study details as provided by Universitätsmedizin Mannheim:

Enrollment: 220
Study Start Date: June 2009
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: electrical velocimetry
    determination of cardiac output by electrical velocimetry
    Device: inert gas rebreathing
    determination of cardiac output by inert gas rebreathing
    Device: spirometry
    spirometry for testing the ventilatory function
    Device: cardiac magnetic resonance imaging (CMR)
    CMR examination which delivers the hemodynamic reference parameters
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Consecutive patients with indication for CMR

Criteria

Inclusion Criteria:

  • Indication for CMR
  • Ability of following instructions for electrical velocimetry test, rebreathing test and spirometry
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00945048

Locations
Germany
1st Department of Medicine, University Hospital Mannheim
Mannheim, Baden-Württemberg, Germany
Sponsors and Collaborators
Universitätsmedizin Mannheim
Investigators
Study Director: Joachim Saur, Dr. 1st Department of Medicine
Study Chair: Jens Kaden, Dr. 1st Department of Medicine
  More Information

No publications provided

Responsible Party: Joachim Saur, Principal Investigator, University Hospital Mannheim
ClinicalTrials.gov Identifier: NCT00945048     History of Changes
Other Study ID Numbers: 2009-MA
Study First Received: July 21, 2009
Last Updated: January 15, 2013
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 20, 2014